We also found that patients with high levels of PDCD1 expression lived longer, indicating that PDCD1 may be protective in the prognosis of NSCLC patients treated with anti-PD-1/PD-L1 (p = 0.043, Figure 10F). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.